Furthermore, cancer cells with elevated activity of E2F1 have been shown to be highly susceptible to HDAC inhibitor induced cell death and more recently HDAC inhibitors such as SAHA have been shown to suppress the activity of EZH2 [81], [82]. Here, EZH2 is linked to cancer.